Vyome Holdings, Inc.
HINDHealthcare|Biotechnology|US
$1.58
-0.05 (-3.07%)
DCF Value
$1.87
Tangible Book / Share
$1.00
Cash / Share
$1.12
Clinical Trials (1)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT03900676 Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris | Acne Vulgaris | P2 | Unknown | 480 | RCT, Double-blind | VB-1953 - 2%, VB-1953 - 0% (Vehicle) |